GN Store Nord
Health Care Equipment
Denmark
ESRS disclosure: ESRS E2 \ DR E2-1 \ Paragraph 15 b
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking's policy address substituting and minimizing the use of substances of concern, and phasing out substances of very high concern, particularly for non-essential societal use and in consumer products, within its own operations and its upstream and downstream value chain?
-
Question Id: E2-1_02
GN’s Environmental Policy includes commitments to substitute or reduce the use of hazardous substances in our own operations and value chain wherever possible. Current and planned actions are undertaken within the parameters of our existing product development programs, financial planning, and business model. For products for which we depend on outsourced manufacturing, the focus is on phasing out halogens, specifically bromine, choline, and fluorine. For Jabra products, requirements for suppliers and verification compliance through in-house testing are set. The phase-out of bromine and chlorine is expected in 2025, and fluorine by 2026 for the same parts.
Report Date: 4Q2024Relevance: 85%
- Provide the total amounts of substances of concern that are generated, used, or procured during production, and specify the total amounts that exit the facilities as emissions, products, or as components of products or services. This information should be categorized according to the main hazard classes of the substances of concern.
-
Question Id: E2-5_04
Overview of substances of concern
Hazard class Amount in litres generated, used or procured during production Amount in litres leaving facilities as products Hazard - Carcogenicity Category 1 150 Category 2 65 Hazard - Chronic hazard to the Aquatic Environment Category 1 6,041 79 Category 2 269 Category 3 625 Category 4 1,418 79 Hazard - Germ Cell Mutagenity Category 2 3 Hazard - Reproductive Toxicity Category 1 3,729 Category 2 1,135 Hazard - Respiratory Sensitisation Category 1 3,096 Hazard - Skin Sensitisation Category 1 6,020 Hazard - Specific Target Organ Toxicity, repeated exposure Category 1 2,861 807 Category 2 385 807 Hazard - Specific Target Organ Toxicity, single exposure Category 1 1,326 Category 2 6 Category 2 1,320 Report Date: 4Q2024Relevance: 85%